Researchers of DZL analyzed lung collagen degradation and found a way to predict the course of an antibody therapy with omalizumab.
COVID-19 disease severity is determined by the individual patient’s immune response. The precise mechanisms taking place inside the lungs and blood during the early phase of the disease remain unclear.
Dr. Gabriele Schramm, a scientist at the DZL site ARCN, has discovered that basophilic granulocytes are important for rapid and efficient recovery after a heart attack.
Prof. Dr. Klaus Rabe and Prof. Dr. Tobias Welte received the ‚Ehrenpreis‘ of the Society for Pediatric Pneumology (GPP) for the year 2020 which was awarded for the first time.
Children growing up on a farm have a lower risk of developing asthma than children not living on a farm. A group of researchers clarified how the children’s gut microbiome is involved in the protection...
DZL scientists published results on asthma diagnosis through breath analysis in the European Respiratory Journal. The results were disappointing, but the conclusions are important.
DZL researchers have found that polymorphisms in a chloride channel gene are associated with asthma, pointing the way towards new therpeutic options.